Last Call

BOSTON – A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones is moving one step closer to being available at your doctor's office.

Johnson & Johnson is going to market the test, and hope to have it available to the public sooner than later.  This is not only a target breakthrough for detecting cancer in those who don't know they have cancer, but it is a giant step towards identifying the cells for destruction and to monitor progress of treatment.

Called a liquid biopsy, this is a non-invasive procedure that would be far more comfortable than the mammograms and colonoscopies that are far from popular.  This would bring in patients who may not be tested otherwise.

This is a major discovery on a lot of fronts, and will advance many discoveries that have been waiting for a moment like this.